Corey Goodman , chief executive of Renovis, says the drug was well worth the wait.

FORBES: Winning A Battle In The War On Stroke

"Pfizer has put its flag in the ground that there is future in regenerative medicine, " said Corey Goodman, president of the company's biotech unit.

FORBES: Magazine Article

Meanwhile Renovis Chief Executive Corey Goodman was facing his own crisis.

FORBES: Brain Repair

Corey Goodman, a former Pfizer executive and founder of biotechs such as Exelixis, a drug developer, and Second Genome, a genetics firm, is one of them.

FORBES: On The Cover/Top Stories

But he has also brought in Corey Goodman, a well-known scientist and biotech entrepreneur, to run a new research center, essentially a biotech-within-Pfizer, in San Francisco.

FORBES: Inside Out At Pfizer

Kindler showed his penchant for creative thinking by also hiring biologist Corey Goodman, the founder of biotechs Exelixis and Renovis, to start what is essentially a parallel research operation in San Francisco.

FORBES: Magazine Article

"A neuroprotectant drug that actually works will have a profound impact on society, " says neuroscientist Corey Goodman, chief executive of Renovis, which, in conjunction with AstraZeneca, is testing a drug it hopes will fill the bill.

FORBES: Brain Repair